KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fulgent Genetics (FLGT) Change in Taxes (2017 - 2025)

Fulgent Genetics' Change in Taxes history spans 8 years, with the latest figure at -$138.7 million for Q4 2025.

  • For Q4 2025, Change in Taxes fell 571.06% year-over-year to -$138.7 million; the TTM value through Dec 2025 reached -$104.9 million, down 1234.09%, while the annual FY2025 figure was -$104.9 million, 1234.09% down from the prior year.
  • Change in Taxes for Q4 2025 was -$138.7 million at Fulgent Genetics, down from -$1.8 million in the prior quarter.
  • Across five years, Change in Taxes topped out at $67.2 million in Q1 2021 and bottomed at -$138.7 million in Q4 2025.
  • The 5-year median for Change in Taxes is -$1.8 million (2024), against an average of -$9.4 million.
  • The largest YoY upside for Change in Taxes was 197555.88% in 2021 against a maximum downside of 162181.03% in 2021.
  • A 5-year view of Change in Taxes shows it stood at -$17.1 million in 2021, then increased by 17.23% to -$14.1 million in 2022, then soared by 116.19% to $2.3 million in 2023, then skyrocketed by 1186.11% to $29.5 million in 2024, then crashed by 571.06% to -$138.7 million in 2025.
  • Per Business Quant, the three most recent readings for FLGT's Change in Taxes are -$138.7 million (Q4 2025), -$1.8 million (Q3 2025), and $33.8 million (Q2 2025).